Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $996M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings Inc | 4,093,785 | $200M | 20.0% | $36.16 | +24.5% | Common | 413197104 |
| — | Sierra Oncology, Inc | 3,329,509 | $183M | 18.4% | $19.74 | — | Common | 82640U404 |
| — | Instil Bio Inc | 12,486,787 | $57.69M | 5.8% | $25.08 | — | Common | 45783C101 |
| — | Iveric Bio Inc | 5,238,634 | $50.4M | 5.1% | $5.94 | — | Common | 46583P102 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38.17M | 3.8% | $6.47 | 0.0% | SHS | P8696W104 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $34.14M | 3.4% | $39.31 | -72.3% | Common | 00166B105 |
| TARS | Tarsus Pharmaceuticals Inc | 2,312,368 | $33.76M | 3.4% | $28.48 | -47.3% | Common | 87650L103 |
| — | Impel NeuroPharma Inc | 2,884,789 | $26.89M | 2.7% | $8.85 | — | Common | 45258K109 |
| GERN | Geron Corp | 15,238,095 | $23.62M | 2.4% | $1.11 | +26.7% | Common | 374163103 |
| VTYX | Ventyx Biosciences Inc | 1,921,726 | $23.5M | 2.4% | $18.57 | -19.5% | Common | 92332V107 |
| — | Amyris, Inc | 11,642,195 | $21.54M | 2.2% | $3.12 | — | Common | 03236M200 |
| COGT | Cogent Biosciences Inc | 1,920,941 | $17.33M | 1.7% | $7.93 | -13.9% | Common | 19240Q201 |
| — | Chinook Therapeutics Inc | 872,151 | $15.25M | 1.5% | $15.86 | — | Common | 16961L106 |
| KALV | KalVista Pharmaceuticals Inc. | 1,533,559 | $15.09M | 1.5% | $15.45 | -28.6% | Common | 483497103 |
| CLDX | Celldex Therapeutics Inc | 558,636 | $15.06M | 1.5% | $11.14 | +160.8% | Common | 15117B202 |
| VRDN | Viridian Therapeutics Inc | 1,300,000 | $15.04M | 1.5% | $14.67 | -8.4% | Common | 92790C104 |
| IOBT | IO Biotech Inc | 3,015,545 | $14.08M | 1.4% | $9.66 | -36.6% | Common | 449778109 |
| — | Genetron Holdings Ltd | 8,124,174 | $13.81M | 1.4% | $9.86 | — | ADS | 37186H100 |
| ASND | Ascendis Pharma A/S | 146,025 | $13.57M | 1.4% | $112.61 | — | SPONSORED ADR | 04351P101 |
| LEGN | Legend Biotech Corp Sponsored | 244,375 | $13.44M | 1.3% | $42.56 | — | SPONSORED ADS | 52490G102 |
| RLMD | Relmada Therapeutics Inc | 705,882 | $13.4M | 1.3% | $22.24 | -1.9% | Common | 75955J402 |
| ACRS | Aclaris Therapeutics, Inc. | 898,631 | $12.54M | 1.3% | $1.36 | +929.5% | Common | 00461U105 |
| — | Verona Pharma PLC | 2,749,918 | $11.52M | 1.2% | $5.20 | — | ADS | 925050106 |
| — | Merus NV | 442,000 | $10.01M | 1.0% | $21.00 | — | Common | N5749R100 |
| ZLAB | Zai Lab Ltd ADR | 271,528 | $9.417M | 0.9% | $62.07 | — | ADR | 98887Q104 |
| — | Bellus Health Inc | 1,017,152 | $9.398M | 0.9% | $8.05 | — | Common | 07987C204 |
| VERA | Vera Therapeutics Inc | 666,666 | $9.073M | 0.9% | $21.52 | -18.9% | Common | 92337R101 |
| — | Bolt Therapeutics Inc | 3,871,291 | $7.897M | 0.8% | $32.91 | — | Common | 097702104 |
| IOVA | Iovance Biotherapeutics Inc | 655,057 | $7.232M | 0.7% | $18.48 | -29.1% | Common | 462260100 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $7.167M | 0.7% | $7.94 | — | ADR | 05337M104 |
| OLMA | Olema Pharmaceuticals Inc | 1,689,515 | $6.876M | 0.7% | $39.90 | -92.1% | Common | 68062P106 |
| DSGN | Design Therapeutics | 476,589 | $6.672M | 0.7% | $31.14 | -56.6% | Common | 25056L103 |
| TERN | Terns Pharmaceuticals Inc | 2,675,133 | $6.634M | 0.7% | $21.92 | -90.9% | Common | 880881107 |
| WHWK | Aadi Bioscience Inc | 509,572 | $6.278M | 0.6% | $30.48 | -51.3% | Common | 00032Q104 |
| CMPX | Compass Therapeutics Inc | 2,000,000 | $5.3M | 0.5% | $3.29 | -34.0% | Common | 20454B104 |
| — | Gracell Biotechnologies Inc | 961,359 | $5.287M | 0.5% | $15.40 | — | SPONSORED ADS | 38406L103 |
| — | Minerva Surgical Inc | 2,215,667 | $5.207M | 0.5% | $5.14 | — | Common | 60343F106 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $5.102M | 0.5% | $5.91 | — | Common | 80405P107 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $4.838M | 0.5% | $40.33 | -6.7% | Common | 04280A100 |
| — | Aligos Therapeutics Inc | 3,547,030 | $4.292M | 0.4% | $27.65 | — | Common | 01626L105 |
| CDXS | Codexis, Inc | 388,144 | $4.06M | 0.4% | $13.98 | -10.3% | Common | 192005106 |
| DYN | Dyne Therapeutics Inc | 577,642 | $3.968M | 0.4% | $20.78 | -66.8% | Common | 26818M108 |
| SERA | Sera Prognostics Inc | 1,856,011 | $3.044M | 0.3% | $10.38 | -81.5% | Common | 81749D107 |
| RZLT | Rezolute Inc | 489,473 | $1.581M | 0.2% | $3.32 | 0.0% | Common | 76200L309 |
| — | Zymeworks Inc | 286,064 | $1.516M | 0.2% | $35.47 | — | Common | 98985W102 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $1.406M | 0.1% | $3.35 | — | ADS | 04522R101 |
| — | Homology Medicines, Inc. | 370,068 | $729K | 0.1% | $15.54 | — | Common | 438083107 |
| — | Precision Biosciences Inc | 140,255 | $224K | 0.0% | $6.03 | — | Common | 74019P108 |
| — | Metacrine Inc | 146,426 | $73,000 | 0.0% | $10.21 | — | Common | 59101E103 |